Elk Creek Partners’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Elk Creek Partners’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-184,334	Closed	-$7.21M	–	143
2018 Q4	$7.21M	Sell	184,334 -31,394	-15%	-$1.36M	0.6%	70
2018 Q3	$11.8M	Buy	215,728 +111,820	+108%	+$7.65M	0.64%	68
2018 Q2	$8.6M	Buy	+103,908	New	+$8.02M	0.47%	92

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Elk Creek Partners's ONCE Position: Q1 2019 in Review

Elk Creek Partners sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 184,334 shares — an estimated $7.21M sold.

Elk Creek Partners first reported a position in ONCE in Q2 2018 and held it in 3 quarters. The position peaked at $11.8M in Q3 2018. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

Elk Creek Partners reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
Elk Creek Partners sold 184,334 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $7.21M.
Elk Creek Partners first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2018 and held it in 3 quarters.
Elk Creek Partners's Spark Therapeutics, Inc. Common Stock position peaked at $11.8M in Q3 2018.
199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Elk Creek Partners's 13F filing for Q1 2019, filed 10 May 2019.